By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is bearish on the near-term prospects of the WBD-Skydance deal, with key risks including regulatory delays, financing issues, and the potential for a deal break rather than a pullback or delay.
Risk: Financing risk if regulatory timeline stretches into Q4, potentially leading to a deal break
Opportunity: None identified
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Unusual Options Activity in WBD Stock Hints the WBD-Paramount Deal Will Close Before August
Will Ashworth
6 min read
As recently as mid-May, Paramount Skydance's (PSKY)$110 billion acquisition of Warner Bros. Discovery (WBD)was on track to close on or before Sept. 30. However, in mid-May, Oliver Darcy's Status newsletter reported that David Ellison was targeting July 15.
On Wednesday, the markets were mixed, but WBD stock gained 1.2% on news that the European Union's regulatory review of the deal would soon be complete and even better, the deal would get EU regulatory approval.
In yesterday's unusual options activity, someone clearly got the memo. Warner Bros. Discovery had the highest Vol/OI (volume-to-open-interest) ratio of options expiring in seven days or more and with at least 500 contracts traded. The July 24 $28 call had a volume of 18,807, 122.17 times the open interest.
Given the previous reporting of the early closing date and WBD's unusual call options activity yesterday, it's clear that someone made a decent-sized bet that the sale would indeed close before July 24.
Should you follow along?
The WBD Options in Question
Four things stand out for me.
1) All four trades expire on the same day, July 24.
2) All four took place at the same time yesterday at 10:37 a.m. ET.
3) The two $30 call trades had a volume of 18,719, as did the two $28 call trades.
4) The open interest on both the $28 and $30 calls had little to no open interest before yesterday's trade.
These four trades suggest someone was doing a large Bull Call Spread split into two parts.
The Bull Call Spread
As you can see from above, I'm using the July 24 $27 and $30 calls as an example of the bull call spread that a trader/investor made in yesterday's trading.
A bull call spread is a bullish bet where you believe WBD stock will increase in value by July 24. It involves buying a $27 call and selling a $30 call. The premium from selling the $30 call offsets the cost of buying the $27 call.
The maximum you could lose on this bull call spread is the net debit of $2.18, which is the $2.25 trade price for the long $27 call, less the $0.07 premium for the short $30 call. Your maximum loss occurs if the share price at expiration is below $27. Your maximum profit would be $0.82 [$30 strike price - $27 strike price - $2.18 net debit]. You achieve maximum profit if the share price is above $30 at expiration. You make some, but not the maximum profit, between the $29.18 breakeven [$27 strike price + $2.18 net debit] and $30.
Now, apply this to the four trades that happened yesterday at 10:37 a.m. ET. Don't be put off by the different-sized trades. It is likely too big a trade to execute as a single clean trade in this situation. The important point is that 18,719 call contracts traded hands yesterday for both the July 24 $28 and $30 calls.
1) The cost of the long $28 calls = $1,871,900 [$1 trade price * 18,719 long $28 calls * 100].
2) The premium of the short $30 calls = $327,500 [($0.18 trade price * 9,360 short $30 calls * 100) + ($0.17 trade price * 9,359 short $30 calls * 100)]. You'll note that if you do the multiplication, it comes out to $327,583, rounded to the nearest penny, because of the different trades made to meet the 18,719 calls.
3) The net debit is $1,544,000 or $0.825 [$1,544,000 / 18,719 contracts / 100 shares]. That is the most the trader could lose. The maximum loss would occur if the share price at expiration is below $28.
4) The maximum profit would be $2,199.482.50 [($30 strike price - $28 strike price - $0.825 net debit) * (18,719 contracts * 100 shares) ], or $1.175.
5) The maximum profit return would be 142.5%.
6) The risk/reward is 0.70 to 1.
7) The profit probability of the $28 long call -- the likelihood that the share price is at the $28.825 breakeven -- as opposed to the $27 long call, would be higher than 28.7%, likely around 29%.
So, whoever made this bet believes there's a 30% chance the deal will close before July 24.
Should You Make This M&A Arbitrage Play?
The short answer is no. The longer answer is more nuanced than that.
Assuming the EU approves the deal before Paramount Skydance CEO David Ellison's July 15 target -- a report yesterday suggested that to meet EU regulatory approval, it will sell its 50% stake in United International Pictures to its joint-venture partner, Universal Pictures, by June 30 -- there remains the approval of the UK Competition and Markets Authority. That's not expected until August.
Further, a coalition of several states (New York, California, and others) are preparing a lawsuit to block the transaction because it reduces competition. This could delay the close until the fall and possibly beyond the Sept. 30 deadline. However, it would be possible for the deal to close after getting EU approval, while still litigating the transaction with the states.
Beyond Sept. 30, Paramount Skydance has agreed to pay a "ticking fee" of 25 cents per share for each quarter after the deadline, in addition to the $110 billion. That amounts to approximately $627.5 million a quarter, according to Morningstar. So, there is a big financial incentive for PSKY to close by Sept. 30.
The trader/investor who made this bet clearly believes the share price will rise over the next 30 days. If further news from the EU's regulatory review emerges during this time, suggesting a timely approval in early August, the bull call spread will clearly possess more value.
The big risk is that one of two things happens before July 24: Either the EU approves the deal unconditionally, or at least signals it will, and the share price pushes up to the $31 purchase price, where the short $30 call becomes a liability, or an unexpected higher bid emerges.
A higher offer is unlikely. The bidder would have to pay a $2.9 billion termination fee to WBD, make an offer in excess of $31 a share, and still navigate a new regulatory approval process. That's just too big a hill to climb.
My guess is the trader/investor will close the position between $29 and $30. It won't want to roll out the bull call spread beyond July 24 because it will effectively lower the potential profit due to the trade cost.
While you could make this trade, I would say your capital is best saved for a more clearly defined risk/reward profile. You're best to leave M&A arbitrage to the professionals.
On the date of publication, Will Ashworth did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Four leading AI models discuss this article
"Regulatory and legal tail risks make a near-term WBD close by July scenario fragile, despite signaling from unusual options activity."
The piece reads like a bets-are-on scenario: a bull call spread on WBD expiring July 24 suggests a ~30% chance the Paramount Skydance deal closes by then. But this is a fragile read. Near-term catalysts exist (EU approval likely soon), yet UK CMA review, potential multi-state antitrust lawsuits, and the ticking-fee structure keep substantial risk of a pullback or delay into fall. Also, the article equates high volume with certainty, which is misleading; spreads can be hedges or synthetic bets. If EU signals in August and CMA stalls, the upside may fade even as volatility spikes.
Against this bullish read, the strongest counter is that regulatory and legal tail risks can extend well beyond July, and even EU signs off doesn't guarantee closure; if the CMA or lawsuits push the timeline into fall, the July 24 options could collapse in value.
"The options volume represents tactical positioning for a short-term regulatory headline, not a fundamental endorsement of the M&A timeline."
The options activity in WBD is a classic 'smart money' signal, but interpreting it as a pure M&A arbitrage play is dangerous. While the $28/$30 bull call spread expiring July 24 suggests confidence in a near-term catalyst, it likely reflects a hedge against a short squeeze or a technical breakout rather than a guaranteed deal closure. The article glosses over the fundamental reality that WBD is currently trading at depressed multiples due to linear TV secular decline and high leverage. Even with EU approval, the domestic regulatory hurdles and the complex debt structure of the combined entity make a July close highly optimistic. I view this activity as speculative positioning ahead of a potential regulatory headline rather than an indicator of structural value.
The unusual volume could be a delta-neutral hedge by a market maker or a sophisticated institutional investor protecting against a sudden upside gap, which would invalidate the 'bullish bet' narrative entirely.
"Unusual options volume is a weak proxy for deal timing; it's a strong signal of near-term bullish sentiment, but the article overstates what the trader's bet actually reveals about deal closure probability."
The article conflates two separate things: unusual options activity and deal timing. Yes, someone bought ~18,700 July 24 $28 calls in a bull spread—that's real. But the author then *infers* this trader believes the deal closes before July 24, when the trade actually just bets WBD stock rises 9% in 30 days. That's a much weaker signal than 'deal closes early.' The UK CMA review (not expected until August) and potential state litigation are genuine blockers the article mentions but doesn't weight heavily enough. The EU approval, while positive, doesn't trigger closing—it's one of several gates. The options activity could just as easily reflect momentum traders betting on near-term stock appreciation independent of deal closure.
If the EU signals unconditional approval this month and the deal momentum accelerates, WBD could easily trade to $30–$31 on pure arbitrage unwind, validating the trader's thesis and making the options bet look prescient rather than speculative.
"The options trade prices in a regulatory timeline the article itself shows is unlikely to be met before July 24."
The July 24 $28/$30 bull call spread in WBD, executed as a single block at 10:37 a.m., prices in roughly a 29-30% chance the stock reaches the $28.825 breakeven by expiration. That timing aligns with David Ellison’s reported July 15 target but collides with the UK CMA review, which the article states is not expected until August, plus pending state AG litigation. Even if the EU clears the deal by June 30 via the UIP divestiture, the $31 deal price remains subject to a ticking fee only after Sept. 30, leaving limited upside before July 24. The 142% max return on a 0.70 risk/reward ratio therefore embeds an aggressive assumption that regulatory timelines compress faster than disclosed.
The UK and state hurdles could be cleared or deferred post-EU approval, allowing the deal to close in August while litigation continues, which would still lift WBD above $28 before the options expire.
"The July spread encodes regulatory sequencing risk and near-term optionality, not a pure delta-neutral hedge."
Gemini flags the July 24 spread as a hedge or delta-neutral play, not a deal bet. I’d push back: the price of a 0.70 debit spread with a 29-30% delta implies meaningful near-term upside optionality that will be heavily influenced by sequencing of EU, CMA, and state litigation—not merely a 'headline-close' catalyst. If CMA drags into August or litigation escalates, the implied odds collapse and the spread acts as a complex directional bet, not a pure hedge.
"Regulatory delays pose a severe risk to the deal's financing structure, which is a more critical failure point than the litigation mentioned by other panelists."
Grok correctly identifies the ticking fee structure, but misses the secondary risk: the deal's financing. Skydance relies on significant external capital. If the regulatory timeline stretches into Q4, the financing commitments could be renegotiated or expire, creating a 'deal break' risk far more binary than mere litigation delays. Claude is right that the options are a momentum play, but the real danger is that the market is mispricing the probability of a financing collapse if regulators stall.
"Financing expiration risk is a binary deal-break that options pricing may not fully capture if regulatory delays stretch into Q4."
Gemini's financing risk is the sharpest point yet—and it's barely priced into the options market. If CMA delays into Q4, Skydance's debt commitments face renegotiation or expiration. But here's the gap: the July 24 spread doesn't just bet on deal closure; it bets WBD trades to $28 regardless. Even if financing collapses, arb unwind or short-squeeze momentum could still hit that strike. The real question is whether financing risk *correlates* with regulatory delay or is independent. If they're linked, the spread is far riskier than the delta suggests.
"Financing collapse would force downward arb unwind, not upward momentum, invalidating the spread's thesis."
Claude overlooks that a financing collapse would trigger outright deal termination, forcing arbitrage desks to unwind long WBD positions and driving the stock sharply lower rather than enabling a short-squeeze to $28. That correlation between Skydance's capital commitments and CMA delays makes the July 24 spread's 29% implied probability look even more aggressive than the regulatory timeline alone suggests.
The panel consensus is bearish on the near-term prospects of the WBD-Skydance deal, with key risks including regulatory delays, financing issues, and the potential for a deal break rather than a pullback or delay.
None identified
Financing risk if regulatory timeline stretches into Q4, potentially leading to a deal break